Medtronic plc
CH ˙ SWX ˙ IE00BTN1Y115
SecurityCH:MDT / Medtronic plc
InstitutionKiltearn Partners LLP
Latest Disclosed Ownership149,561 shares
Latest Disclosed Value $ 12,959,461
Kiltearn Partners LLP reports 17.26% decrease in ownership of MDT / Medtronic plc

On May 14, 2026 - Kiltearn Partners LLP filed a 13F-HR form disclosing ownership of 149,561 shares of Medtronic plc (CH:MDT) valued at $12,959,461 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 180,761 shares of Medtronic plc. This represents a change in shares of -17.26% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F MEDTRONIC SHS G5960L103 149,561 -31,200 -17.26 12,959 -25.36 3.4869
2026-02-13 2025-12-31 13F MEDTRONIC SHS G5960L103 180,761 -35,800 -16.53 17,364 -15.82 3.7612
2025-11-13 2025-09-30 13F MEDTRONIC SHS G5960L103 216,561 -16,200 -6.96 20,625 1.66 4.1339
2025-08-13 2025-06-30 13F MEDTRONIC SHS G5960L103 232,761 -18,800 -7.47 20,290 -10.25 4.0797
2025-05-14 2025-03-31 13F MEDTRONIC SHS G5960L103 251,561 -44,700 -15.09 22,605 -4.48 4.3081
2025-02-12 2024-12-31 13F MEDTRONIC SHS G5960L103 296,261 -31,600 -9.64 23,665 -19.83 3.9103
2024-11-13 2024-09-30 13F MEDTRONIC SHS G5960L103 327,861 -31,900 -8.87 29,517 4.24 4.0124
2024-08-14 2024-06-30 13F MEDTRONIC SHS G5960L103 359,761 25,900 7.76 28,317 -2.53 3.4330
2024-05-15 2024-03-31 13F MEDTRONIC SHS G5960L103 333,861 -62,200 -15.70 29,053 -10.96 2.6852
2024-02-13 2023-12-31 13F MEDTRONIC SHS G5960L103 396,061 154,961 64.27 32,628 72.70 2.5110
2023-11-13 2023-09-30 13F MEDTRONIC SHS G5960L103 241,100 -8,400 -3.37 18,893 -14.05 1.4922
2023-08-10 2023-06-30 13F MEDTRONIC SHS G5960L103 249,500 -7,500 -2.92 21,981 6.09 1.6069
2023-05-15 2023-03-31 13F MEDTRONIC SHS G5960L103 257,000 61,500 31.46 20,719 36.36 1.4965
2023-02-09 2022-12-31 13F MEDTRONIC SHS G5960L103 195,500 195,500 15,194 1.1152
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.